Changing frequency of interim analysis in sequential monitoring.
暂无分享,去创建一个
In clinical trial data monitoring, one can either introduce a discrete sequential boundary for a set of specified decision times or adopt a use function and then derive the boundary when data are monitored. If the use function approach is employed, one can adjust the frequency of data monitoring as long as the decision is not data-dependent. However, if the frequency of future data monitoring is affected by the observed data, then the probability of Type I error will no longer be preserved exactly. But the effect on the significance level and power is very small, perhaps negligible, as indicated by simulation results.
[1] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[2] David M. De Long. Crossing probabilities for a square root boundary by a bessel process , 1981 .
[3] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[4] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .